Introduction S1 Pharmacological actions S2 Traumatic lesions and experimental cerebral oedema S2 Cerebral hypoxia and ischaemia S5 Synaptic transmission and neurotransmitter levels S13 Learning performance, memory and brain ageing S17 Experimental withdrawal syndrome and intoxications S19 Toxicity S20 Acute toxicity S20 Subacute toxicity S20 Chronic toxicity S20 Teratogenicity S20 Pharmacokinet...

This review is based on the previous one published in 2010 -Secades JJ. Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62-, incorporating 183 new references, having all the information available to facilitate the access to the information in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae...

Every year, about 150,000 strokes occur in Ukraine, and more than 100,000 people die from the consequences of stroke other circulatory disorders brain. So far, promising experimental data on treatment neurological dysfunction using mesenchymal stromal cells (MSCs) have been obtained. Purpose: to characterize impact MSCs various origins, lysate Wharton’s jelly-derived citicoline dynamics destruc...